These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 28785216)

  • 1. MicroRNA-4639 Is a Regulator of DJ-1 Expression and a Potential Early Diagnostic Marker for Parkinson's Disease.
    Chen Y; Gao C; Sun Q; Pan H; Huang P; Ding J; Chen S
    Front Aging Neurosci; 2017; 9():232. PubMed ID: 28785216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of Hsa-miR-4639-5p expression and its potential role in the pathogenesis of Parkinson's disease.
    He L; Chen Y; Lin S; Shen R; Pan H; Zhou Y; Wang Y; Chen S; Ding J
    Aging Cell; 2023 Jun; 22(6):e13840. PubMed ID: 37101349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of plasma microRNA expression changes in multiple system atrophy and Parkinson's disease.
    Uwatoko H; Hama Y; Iwata IT; Shirai S; Matsushima M; Yabe I; Utsumi J; Sasaki H
    Mol Brain; 2019 May; 12(1):49. PubMed ID: 31088501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated Plasma microRNA-105-5p Level in Patients With Idiopathic Parkinson's Disease: A Potential Disease Biomarker.
    Yang Z; Li T; Cui Y; Li S; Cheng C; Shen B; Le W
    Front Neurosci; 2019; 13():218. PubMed ID: 30936821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant expression of microRNA-132-3p and microRNA-146a-5p in Parkinson's disease patients.
    Shu Y; Qian J; Wang C
    Open Life Sci; 2020; 15(1):647-653. PubMed ID: 33817253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of gut miRNAs in idiopathic Parkinson's disease.
    Kurz A; Kumar R; Northoff BH; Wenk C; Schirra J; Donakonda S; Höglinger GU; Schwarz J; Rozanski V; Hübner R; Bötzel K; Holdt LM; Koeglsperger T
    Parkinsonism Relat Disord; 2021 Jul; 88():46-50. PubMed ID: 34118643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberration of miRNAs Expression in Leukocytes from Sporadic Amyotrophic Lateral Sclerosis.
    Chen Y; Wei Q; Chen X; Li C; Cao B; Ou R; Hadano S; Shang HF
    Front Mol Neurosci; 2016; 9():69. PubMed ID: 27582688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptomics and Proteomics Approach for the Identification of Altered Blood microRNAs and Plasma Proteins in Parkinson's Disease.
    Yadav SK; Jauhari A; Singh N; Pandey A; Sarkar S; Pandey S; Garg RK; Parmar D; Yadav S
    Cell Mol Neurobiol; 2023 Oct; 43(7):3527-3553. PubMed ID: 37219663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulated Serum MiRNA Profile and Promising Biomarkers in Dengue-infected Patients.
    Ouyang X; Jiang X; Gu D; Zhang Y; Kong SK; Jiang C; Xie W
    Int J Med Sci; 2016; 13(3):195-205. PubMed ID: 26941580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of plasma microRNAs as a biomarker of sporadic Amyotrophic Lateral Sclerosis.
    Takahashi I; Hama Y; Matsushima M; Hirotani M; Kano T; Hohzen H; Yabe I; Utsumi J; Sasaki H
    Mol Brain; 2015 Oct; 8(1):67. PubMed ID: 26497046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening and identification of potential novel biomarker for diagnosis of complicated Plasmodium vivax malaria.
    Kaur H; Sehgal R; Kumar A; Sehgal A; Bansal D; Sultan AA
    J Transl Med; 2018 Oct; 16(1):272. PubMed ID: 30286756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral whole blood microRNA alterations in major depression and bipolar disorder.
    Maffioletti E; Cattaneo A; Rosso G; Maina G; Maj C; Gennarelli M; Tardito D; Bocchio-Chiavetto L
    J Affect Disord; 2016 Aug; 200():250-8. PubMed ID: 27152760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible role of hsa-miR-194-5p, via regulation of HS3ST2, in the pathogenesis of atopic dermatitis in children.
    Meng L; Li M; Gao Z; Ren H; Chen J; Liu X; Cai Q; Jiang L; Ren X; Yu Q; Chen J; Yang L
    Eur J Dermatol; 2019 Dec; 29(6):603-613. PubMed ID: 31903950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The biomarker potential of cell-free microRNA from cerebrospinal fluid in Parkinsonian Syndromes.
    Starhof C; Hejl AM; Heegaard NHH; Carlsen AL; Burton M; Lilje B; Winge K
    Mov Disord; 2019 Feb; 34(2):246-254. PubMed ID: 30557454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum miR-96-5P and miR-339-5P Are Potential Biomarkers for Multiple System Atrophy and Parkinson's Disease.
    Vallelunga A; Iannitti T; Capece S; Somma G; Russillo MC; Foubert-Samier A; Laurens B; Sibon I; Meissner WG; Barone P; Pellecchia MT
    Front Aging Neurosci; 2021; 13():632891. PubMed ID: 34381349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma.
    Pereira TDSF; Brito JAR; Guimarães ALS; Gomes CC; de Lacerda JCT; de Castro WH; Coimbra RS; Diniz MG; Gomez RS
    J Oral Pathol Med; 2018 Jan; 47(1):78-85. PubMed ID: 29032608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-494 reduces DJ-1 expression and exacerbates neurodegeneration.
    Xiong R; Wang Z; Zhao Z; Li H; Chen W; Zhang B; Wang L; Wu L; Li W; Ding J; Chen S
    Neurobiol Aging; 2014 Mar; 35(3):705-14. PubMed ID: 24269020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypothesis: Do miRNAs Targeting the Leucine-Rich Repeat Kinase 2 Gene (LRRK2) Influence Parkinson's Disease Susceptibility?
    Yılmaz ŞG; Geyik S; Neyal AM; Soko ND; Bozkurt H; Dandara C
    OMICS; 2016 Apr; 20(4):224-8. PubMed ID: 27093107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating miRNA-21-5p as a diagnostic biomarker for pancreatic cancer: evidence from comprehensive miRNA expression profiling analysis and clinical validation.
    Qu K; Zhang X; Lin T; Liu T; Wang Z; Liu S; Zhou L; Wei J; Chang H; Li K; Wang Z; Liu C; Wu Z
    Sci Rep; 2017 May; 7(1):1692. PubMed ID: 28490741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 9-microRNA Signature in Serum Serves as a Noninvasive Biomarker in Early Diagnosis of Alzheimer's Disease.
    Guo R; Fan G; Zhang J; Wu C; Du Y; Ye H; Li Z; Wang L; Zhang Z; Zhang L; Zhao Y; Lu Z
    J Alzheimers Dis; 2017; 60(4):1365-1377. PubMed ID: 29036818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.